AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.7 Out of 5 (3619 Reviews)

What I like most about KSquare is the clarity and control I have over my investments. SIPs have never been easier to manage.

Nikhil Arora

Nikhil Arora

UX Designer

Thanks to KSquare, I started my investment journey the right way. Their mutual fund options are diverse, affordable, and super easy to manage.

Devansh Solanki

Devansh Solanki

Tourism Consultant

KSquare not only alerts about NFOs, but they explain fund purpose and performance projections. I truly appreciate that extra layer of detail and care.

Aditya Chauhan

Aditya Chauhan

Systems Engineer

KSquare offers outstanding NFO briefings that help investors understand the market fit. They truly empower clients with knowledge before any commitment.

Pranav Goel

Pranav Goel

Economics Professor

KSquare provides a transparent and smooth mutual fund experience. Their portfolio tools are user-friendly, and I love how effortless it feels to invest monthly.

Ritesh Bansal

Ritesh Bansal

Mechanical Engineer

KSquare helped me invest in Indian markets with zero stress. Their NRI Corner is truly designed for people living abroad.

Ira D’Souza

Ira D’Souza

Startup Advisor

KSquare’s loan facility saved me during a financial crunch. I didn’t need to touch my investments—very helpful!

Rajeev Kapoor

Rajeev Kapoor

Plant Manager

Mutual fund investing with KSquare has been fantastic. I appreciate their attention to risk profiling and how they tailor recommendations. It’s an empowering experience.

Kavya Iyer

Kavya Iyer

Biotech Researcher

I recommend KSquare to anyone who’s unsure about mutual funds. Their platform is supportive, beginner-friendly, and offers great fund insights to plan ahead.

Shraddha Menon

Shraddha Menon

Education Consultant

With KSquare, SIP investments have become a habit I enjoy. They offer flexibility, insights, and a clean interface. Truly made investing part of my routine.

Harsh Kapoor

Harsh Kapoor

Digital Marketer

FAQ's

Frequenlty Asked Question

Does KSquare provide regular portfolio updates?

Yes, clients receive consistent performance updates and guidance, ensuring investments remain aligned with goals at every stage.

Is SIP suitable for business owners too?

SIP is equally beneficial for business owners, helping them invest steadily despite fluctuating income.

What if I fail to repay the loan on time?

In case of default, the lender may sell pledged mutual fund units. KSquare advises timely repayment to avoid any financial impact.

Do SIPs help in achieving children’s education goals?

Yes, SIPs offer structured savings and growth, ensuring funds are ready when needed for future school, college or career plans.

What types of accounts are required for NRI investments?

NRIs need either an NRE or NRO account to start investing through KSquare, depending on fund repatriation needs.

What is the National Pension System (NPS)?

NPS is a government-backed retirement savings scheme that lets you invest during your working life and withdraw upon retirement.

Can I invest in mutual funds online through KSquare?

Yes, KSquare’s digital platform allows you to browse, select, and invest in mutual funds entirely online.

What happens to my NPS account if I change jobs?

NPS is portable across employers, so your contributions continue seamlessly without any disruption or need for new registration.

App Store